Medicine
LYUMJEV Junior KwikPen 100 IU/mL injection
LYUMJEV Junior KwikPen 100 IU/mL injection is a prescription medicine containing Insulin lispro for subcutaneous use, marketed by Eli Lilly, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Conditions for Vials, Pens, and Cartridges a In-use (opened) vials, whether or…
Key facts
- Active ingredient (INN)
- Insulin lispro
- Brand
- LYUMJEV Junior KwikPen
- Strength
- 100 IU/mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 5 syringes
- Marketing authorisation holder
- Eli Lilly
- Manufacturer
- Eli Lilly
- Origin register
- US FDA, United States
- Storage
- Conditions for Vials, Pens, and Cartridges a In-use (opened) vials, whether or not refrigerated, must be used within 28 days. b When stored at room temperature, LYUMJEV can only be used for a total of 28 days including both not in-use (unopened) and in-use (opened) storage time.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10AB04 Insulin lispro
- HS code (indicative)
- 3004.31Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 June 2020
- Identifiers
- RxCUI 2380231, 2380236, 2380248 +7DailyMed set ID c5a056e2-b568-4ca6-9ed8-79c010942d00NDC 0002-8351Application BLA761109
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 syringe in 1 carton / 3 mL in 1 syringe | 0002-8351-05 | Eli Lilly | 15 June 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Insulin lispro 100 IU/mL injection.
- Humalog 100 IU/mL injectionAvailable on requestEli LillyUS FDA4 packs
- Humalog KwikPen 100 IU/mL injectionAvailable on requestEli LillyUS FDA3 packs
- Insulin lispro 100 IU/mL injectionAvailable on request—US FDA2 packs
- Lyumjev 100 IU/mL injectionAvailable on requestEli LillyUS FDA2 packs Cold chain
- Humalog Junior KwikPen 100 IU/mL injectionAvailable on requestEli LillyUS FDA1 pack
- Humalog Tempo Pen 100 IU/mL injectionAvailable on requestEli LillyUS FDA1 pack
Other strengths and forms of Insulin lispro
Clinical summary
Insulin lispro is an insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. It is available as injection and injectable suspension for subcutaneous and intravenous use. MedsAcross supplies Insulin lispro for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Insulin lisproFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ADMELOG prescribing information (Sanofi-Aventis) · U.S. National Library of Medicine, DailyMed
- Humalog: European public assessment report (EPAR) · European Medicines Agency
- Liprolog: European public assessment report (EPAR) · European Medicines Agency
Need LYUMJEV Junior KwikPen 100 IU/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.